6-Phenoxy-2-phenylbenzoxazoles, novel inhibitors of receptor for advanced glycation end products (RAGE).

[1]  Jianling Xie,et al.  Cellular signalling of the receptor for advanced glycation end products (RAGE). , 2013, Cellular signalling.

[2]  I. Hamley.  The amyloid beta peptide: a chemist's perspective. Role in Alzheimer's and fibrillization. , 2012, Chemical reviews.

[3]  Hyun-Ju Park,et al.  Ligand-based design, synthesis, and biological evaluation of 2-aminopyrimidines, a novel series of receptor for advanced glycation end products (RAGE) inhibitors. , 2012, Journal of medicinal chemistry.

[4]  Nathan T. Ross,et al.  A multimodal RAGE-specific inhibitor reduces amyloid β-mediated brain disorder in a mouse model of Alzheimer disease. , 2012, The Journal of clinical investigation.

[5]  G. Fritz.  RAGE: a single receptor fits multiple ligands. , 2011, Trends in biochemical sciences.

[6]  B. Zlokovic.  Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders , 2011, Nature Reviews Neuroscience.

[7]  B. Strooper,et al.  The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics , 2011, Nature Reviews Drug Discovery.

[8]  G. McKhann,et al.  RAGE-mediated signaling contributes to intraneuronal transport of amyloid-β and neuronal dysfunction , 2009, Proceedings of the National Academy of Sciences.

[9]  Hiroshi Yamamoto,et al.  RAGE in diabetic nephropathy. , 2007, Current molecular medicine.

[10]  T. Arumugam,et al.  RAGE and RAGE ligands in cancer. , 2007, Current molecular medicine.

[11]  K. Herold,et al.  Receptor for AGE (RAGE): weaving tangled webs within the inflammatory response. , 2007, Current molecular medicine.

[12]  Xi Chen,et al.  RAGE potentiates Aβ‐induced perturbation of neuronal function in transgenic mice , 2004, The EMBO journal.

[13]  L A Hansen,et al.  The importance of neuritic plaques and tangles to the development and evolution of AD , 2004, Neurology.

[14]  V. D’Agati,et al.  Blockade of receptor for advanced glycation endproducts: a new target for therapeutic intervention in diabetic complications and inflammatory disorders. , 2003, Archives of biochemistry and biophysics.

[15]  Claudia H. Kawas,et al.  Early Alzheimer's Disease , 2003 .

[16]  Ann Marie Schmidt,et al.  RAGE mediates amyloid-β peptide transport across the blood-brain barrier and accumulation in brain , 2003, Nature Medicine.

[17]  T. Kislinger,et al.  RAGE Blockade Stabilizes Established Atherosclerosis in Diabetic Apolipoprotein E–Null Mice , 2002, Circulation.

[18]  L. Lue,et al.  Involvement of Microglial Receptor for Advanced Glycation Endproducts (RAGE) in Alzheimer's Disease: Identification of a Cellular Activation Mechanism , 2001, Experimental Neurology.

[19]  D. Holtzman,et al.  Clearance of amyloid β-peptide from brain: transport or metabolism? , 2000, Nature Medicine.

[20]  C. Soto,et al.  Receptor-dependent cell stress and amyloid accumulation in systemic amyloidosis , 2000, Nature Network Boston.

[21]  M. Neurath,et al.  RAGE Mediates a Novel Proinflammatory Axis A Central Cell Surface Receptor for S100/Calgranulin Polypeptides , 1999, Cell.

[22]  B. Zlokovic,et al.  Human blood-brain barrier receptors for Alzheimer's amyloid-beta 1- 40. Asymmetrical binding, endocytosis, and transcytosis at the apical side of brain microvascular endothelial cell monolayer. , 1998, The Journal of clinical investigation.

[23]  X. Chen,et al.  Amyloid- (cid:98) peptide–Receptor for Advanced Glycation Endproduct interaction elicits neuronal expression of macrophage-colony stimulating factor: A proinflammatory pathway in Alzheimer disease , 1997 .

[24]  X. Chen,et al.  RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease , 1996, Nature.

[25]  J. Chen,et al.  The Receptor for Advanced Glycation End Products (RAGE) Is a Cellular Binding Site for Amphoterin , 1995, The Journal of Biological Chemistry.

[26]  B. Zlokovic,et al.  Blood-brain barrier transport of circulating Alzheimer's amyloid beta. , 1993, Biochemical and biophysical research communications.

[27]  K. O. Elliston,et al.  Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins. , 1992, The Journal of biological chemistry.

[28]  W. Hurley,et al.  Isolation and characterization of two binding proteins for advanced glycosylation end products from bovine lung which are present on the endothelial cell surface. , 1992, The Journal of biological chemistry.

[29]  S. Yan,et al.  RAGE and Alzheimer's disease: a progression factor for amyloid-beta-induced cellular perturbation? , 2009, Journal of Alzheimer's disease : JAD.